News & Articles

Over 200 exhibitors, AI-powered breakthroughs, and strategic forums set to transform regional healthcare

How cross-disciplinary collaboration and earlier recognition can transform outcomes for patients with Crohn’s disease and ulcerative colitis

The partnership aims to support cell therapy researchers with a standardized and reliable MSC reference system

The ORCA-Halo combines cutting-edge reliable technology with excellent image quality performance

A key focus of the partnership will be the development of adeno-associated virus gene therapy programs using intellectual property from KU Leuven

Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies

The new site is still within the Midlothian Science Zone and is now fully operational, marking a significant milestone in the company’s continued growth

Licensing with a global enzyme provider for two Optimer reagents in research and diagnostics

New solutions from Siemens Healthineers address labs’ environmental and efficiency goals

BUCHI sets a new standard in material analysis, offering tailored solutions for quality assurance at every stage of the supply chain

The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases

Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress

A study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival

New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow

1 in 3 Phase II trials were terminated in 2024

The UG 100 offers a cost-effective and extremely low-error sequencing profile

Dive into a new era of intelligence and performance with Agilent's upcoming virtual launch

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.

New test format enhances commercialisation potential

Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency

The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment

Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform